Abstract
Thyroid hormone receptors (TRs) and retinoic acid receptors (RARs) are nuclear hormone receptors that play crucial roles in embryogenesis, cell proliferation, differentiation, and metabolism. TRs and RARs repress basal transcription in the absence of ligand and activate transcription upon ligand binding in positively-regulated target genes (1–3). TRs and RARs mediate basal repression through interactions with corepressors, such as nuclear receptor corepressor (NcoR) and silencing mediator for retinoid and thyroid hormone receptors (SMRT) (4,5). NCoR and SMRT are both 270 kDa proteins that have 43% amino acid homology (4,5). These corepressors have two nuclear hormone receptor interaction domains in the carboxy terminus and three transferable repression domains in the amino terminus (RD1, RD2, RD3) (3,6). RD1 and a region downstream of RD3 have been shown to recruit histone deacetylases (HDAC1 and HDAC2) through direct interaction with Sin3B (3,6-9). The TR/corepressor/sin3/HDAC causes hypoacetylation of local histones, which then results in conformational changes in the nucleosome structure and decreases access of enhancers and components of the basal transcriptional machinery to the promoter region and transcriptional start site (7-10). In contrast to basal repression, histone acetylation plays an important role in transcription as p160 coactivators and associated cofactors are recruited by liganded TR, which then forms complexes that contain histone acetyltransferase activity (11). These complexes may then exchange with other complexes that share components with the RNA pol II transcriptional initiation complex (12,13).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oppenheimer, J. A., Schwartz, H. L., Mariash, C. N., Kinlaw, W. B., Wong, N. C. W., and Freake, H. C. (1987) Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8, 288–308.
Pibiri, M., Ledda-Columbano, G. M., Cossu, C., et al. 2001 Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J. 15, 1006–1013.
Seol, W., Mahon, M. J., Lee, Y. K., and Moore, D. D. (1996) Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10, 1646–1655.
Horlein, A. J., Naar, A. M., Heinzel, T., et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397–404
Chen, J. D. and Evans, R. M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454–157.
Li, H., Leo, C., Schroen, D. J., and Chen, J. D. (1997) Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11, 2025–2037.
Alland, L., Muhle, R., Hou, H., Jr., et al. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49–55.
Heinzel, T., Lavinsky, R. M., Mullen, T. M., et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43–48.
Nagy, L., Kao, H. Y., Chakravarti, D., et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3 A, and histone deacetylase. Cell 89, 373–380.
Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E., and Eisenman, R. N. (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349–356.
McKenna, N. J., Lanz, R. B., and O’Malley, B. W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321–344.
Rachez, C., Lemon, B. D., Suldan, Z., et al. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824–828.
Ito, M., Yuan, C. X., Malik, S., et al. (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell Biol. 3, 361–370.
Jepsen, K., Hermanson, O., Onami, T. M., et al. (2000) Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102, 753–763.
Hassig, C. A. and Schreiber, S. L. (1997) Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300–308.
Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599–606
Zamir, I., Harding, H. P., Atkins, G. B., et al. (1996) A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16, 5458–5465.
Shibata, H., Nawaz, Z., Tsai, S. Y., O’Malley, B. W., and Tsai, M. J. (1997) Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11, 714–724.
Bailey, P., Downes, M., Lau, P., et al. (1999) The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol. Endocrinol. 13, 1155–1168.
Grignani, F., De Matteis, S., Nervi, C., et al. (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815–818.
He, L. Z., Guidez, F., Tribioli, C., et al. (1998) Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat. Genet. 18, 126–135.
Dhordain, P., Albagli, O., Lin, R. J., et al. (1997) Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA 94, 10,762–10,767.
Lazar, M. A. (1999) Nuclear hormone receptors: from molecules to diseases. J. Investig. Med. 47, 364–368.
Muscat, G. E., Burke, L. J., and Downes, M. (1998) The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucl. Acids Res. 26, 2899–2907.
Zhang, L., Zhou., Velculescu, V. E., et al. (1997) Gene expression profiles in normal and cancer cells. Science 276, 1268–1272.
Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.
Duggan, D. J., Bittner, M., Chen, Y., Meltzer, P., and Trent, J. M. (1999) Expression profiling using cDNA microarrays. Nat. Genet. 21, 10s–14s.
Khan, J., Bittner, M. L., Saal, L. H., et al. (1999) cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96, 13,264–13,269.
Iyer, V. R., Eisen, M. B., Ross, D. T., et al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283, 83–87.
Wang, K., Gan, L., Jeffery, E., et al. (1999) Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229, 101–108.
DeRisi, J., Penland, L., Brown, P. O., et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457–460.
Lee, C. K., Klopp, R. G., Weindruch, R., and Prolla, T. A. (1999) Gene expression profile of aging and its retardation by caloric restriction. Science 285, 1390–1393.
Spellman, P. T., Sherlock, G., Zhang, M. Q., et al. (1998) Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell. 9, 3273–3297.
Bryant Z., Subrahmanyan, L., Tworoger, M., et al. (1999) Characterization of differentially expressed genes in purified Drosophila follicle cells: toward a general strategy for cell type-specific developmental analysis. Proc. Natl. Acad. Sci. USA 96, 5559–5564.
Khan, J., Saal, L. H., Bittner, M. L., Chen, Y., Trent, J. M., and Meltzer, P. S. (1999) Expression profiling in cancer using cDNA microarrays. Electrophoresis 20, 223–229.
Feng, X., Jiang, Y., Meltzer, P., and Yen, P. M. (2000) Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14, 947–955.
Hollenberg, A. N., Monden, T., Madura, J. P., Lee, K., and Wondisford, F. E. (1996) Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J. Biol. Chem. 271, 28,516–28,520.
Kawamura, T., Furusaka, A., Koziel, M. J., et al. (1997) Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25, 1014–1021.
Tagami, T., Madison, L. D., Nagaya, T., and Jameson, J. L. (1997) Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol. Cell. Biol. 17, 2642–2648.
Xu, J., Qiu, Y., DeMayo, F. J., Tsai, S. Y., Tsai, M. J., and O’Malley, B. W. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279, 1922–1925.
Camps, M., Nichols, A., and Arkinstall, S. (2000) Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14, 6–16.
Phaneuf, D., Chen, S. J., and Wilson, J. M. (2000) Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol. Med. 6, 96–103.
Snibson, K. J., Bhathal, P. S., Hardy, C. L., Brandon, M. R., and Adams, T. E. (1999) High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. Liver 19, 242–252.
Camps, M., Nichols, A., and Arkinstall, S. (2000) Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14, 6–16.
Hong, S. H. and Privalsky, M. L. (2000) The SMRT corepressor is regulated by a MEK-1 kinase pathway: iInhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol. Cell. Biol. 20, 6612–6625.
Payraudeau, V., Sarsat, J. P., Sobczak, J., Brechot, C., and Albaladejo, V. (1998) Cyclin A2 and c-myc mRNA expression in ethinyl estradiol induced liver proliferation. Mol. Cell. Endocrinol. 143, 107–116.
Blanchard, J. (2000) Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues. Biochem. Pharmacol. 60, 1179–1184.
Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control Cell 81, 323–330.
Tabor, E. (1994) Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol. 42, 357–365.
Dang, C.V. 1999 c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1–11.
Coller, H. A., Grandori, C., Tamayo, P., et al. (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97, 3260–3265.
Henriksson, M. and Luscher, B. (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109–182.
Amati, B., Frank, S. R., Donjerkovic, D., and Taubert, S. (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta. 1471, M135–M145.
Rao, G., Alland, L., Guida, P., et al. (1996) Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene 12, 1165–1172.
Ayer, D. E., Lawrence, Q. A., and Eisenman, R. N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767–776
Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J, and Lukas, J. (2000) Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20, 3497–3509.
Johnson, D. G. and Walker, C. L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295–312.
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L, Bannister, A. J., and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601.
Lai, A., Kennedy, B. K., Barbie, D. A., et al. (2001) RBP1 Recruits the mSIN3Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest. Mol. Cell. Biol. 21, 2918–2932.
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., et al. (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391 601–605.
Na, S. Y., Choi, J. E., Kim, H. J., Jhun, B. H., Lee, Y. C., and Lee, J. W. (1999) Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation. J. Biol. Chem. 274, 28,491–28,496.
Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., and Baltimore, D. (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7, 1354–1363.
Ohno, H., Takimoto, G., and McKeithan, T. W. (1990) The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60, 991–997.
Na, S. Y., Choi, H. S., Kim, J. W., Na, D. S., and Lee, J. W. (1998) an IkappaB protein, as a novel transcription coactivator of the retinoid X receptor. J. Biol. Chem. 273, 30,933–30,938.
Rebollo, A., Dumoutier, L., Renauld, J. C., Zaballos, A., Ayllon, V., and Martinez, A. C. (2000) Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol. Cell. Biol. 20, 3407–3416.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Feng, X., Meltzer, P., Yen, P.M. (2002). Transgenic Targeting of a Dominant Negative Corepressor to Liver and Analyses by cDNA Microarray. In: Baniahmad, A. (eds) Thyroid Hormone Receptors. Methods in Molecular Biology, vol 202. Humana Press. https://doi.org/10.1385/1-59259-174-4:31
Download citation
DOI: https://doi.org/10.1385/1-59259-174-4:31
Publisher Name: Humana Press
Print ISBN: 978-0-89603-995-7
Online ISBN: 978-1-59259-174-9
eBook Packages: Springer Protocols